Clinical Trials

42 enrolled

Prostatic Neoplasms

NCT04693377 2026-04-15

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

40 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Prostatic Neoplasms, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT05361798 2026-04-06

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

65 enrolled

Prostatic Neoplasms

NCT04423211 2026-04-03

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

804 enrolled

Prostatic Neoplasms

NCT05946213 2026-04-03

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

1,209 enrolled

Prostatic Neoplasms

NCT06500455 2026-04-03

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

BreastCNSDermatologicGenitourinaryThoracic

269 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT06325046 2026-03-31

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

144 enrolled

Prostatic Neoplasms

NCT02016248 2026-03-30

SBRT Boost for Unfavorable Prostate Cancer'

150 enrolled

Prostatic Neoplasms

NCT04235777 2026-03-27

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

Phase 1 Recruiting

100 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT07426055 2026-03-23

PRO-BOOST-LC

Phase 2/3 Recruiting

1,200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07189598 2026-03-19

ORION

390 enrolled

Prostatic Neoplasms

NCT06523634 2026-03-12

STEREOBED

284 enrolled

Prostatic Neoplasms

NCT06369246 2026-03-09

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

Phase 1 Recruiting

70 enrolled

Advanced Prostate Cancer

NCT07451795 2026-03-05

SHARP

66 enrolled

Prostatic Neoplasms

NCT06835725 2026-02-27

ADAPT-25

100 enrolled

Prostate CA

NCT04983095 2026-02-17

METRO

118 enrolled

Prostate Cancer Metastatic

NCT03073278 2026-02-06

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

36 enrolled

Locally Recurrent Prostate Cancer

NCT04610372 2026-02-02

PROMPT

168 enrolled

Oligometastatic Prostate Cancer

NCT06397703 2026-01-28

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

392 enrolled

Prostatic Neoplasms

NCT04402151 2026-01-26

PSMA SBRT-SIB

50 enrolled

Prostatic Neoplasms

NCT07299357 2026-01-21

Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial

Recruiting

53 enrolled

Kidney Neoplasms

NCT06205316 2026-01-20

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

118 enrolled

Prostatic Neoplasms

NCT05038332 2026-01-16

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

136 enrolled

Prostatic Neoplasms

NCT06726421 2026-01-15

STROKER

252 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05830058 2026-01-05

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

DermatologicGenitourinaryThoracic

32 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT06378866 2025-12-26

DIVINE

532 enrolled

Prostatic Neoplasms

NCT04536805 2025-12-08

REPAIR

Phase 1/2 Recruiting

44 enrolled

Prostatic Neoplasms

NCT04974671 2025-12-04

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

30 enrolled

Carcinoma, Renal Cell, Disease Progression

NCT05893381 2025-12-03

LUST

70 enrolled

Prostatic Neoplasms

NCT07219303 2025-10-29

DE-CART

80 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06320067 2025-09-26

STAMPEDE2

3,360 enrolled

Prostate Cancer Metastatic

NCT06927635 2025-09-05

SECURE

75 enrolled

Castrate Resistance Prostate Cancer

NCT06255223 2025-09-03

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

35 enrolled

Carcinoma, Renal Cell

NCT07142967 2025-08-27

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

28 enrolled

Intraprostatic Prostate Cancer

NCT04552509 2025-07-22

TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

167 enrolled

Prostatic Neoplasms

NCT04945642 2025-07-15

HYDRA

52 enrolled

Prostatic Neoplasms

NCT06625970 2025-06-26

PEACE 7

700 enrolled

Prostatic Neoplasms

NCT04004312 2025-06-25

Single Fractions SBRT for Prostate Cancer

12 enrolled

Prostatic Neoplasms

NCT04915508 2025-06-22

EXCALIBUR

102 enrolled

Prostatic Neoplasms

NCT06546267 2025-06-11

PROST-ART

Recruiting

2,500 enrolled

Lymphatic Metastasis, Prostatic Neoplasms

NCT05915442 2025-05-20

SBRT-AMICO

23 enrolled

Oligometastatic Prostate Cancer

NCT05169970 2025-05-08

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

215 enrolled

Prostatic Neoplasms

NCT06201078 2025-03-13

PROSTARE

55 enrolled

Local Recurrence of Malignant Tumor of Prostate

NCT06276465 2024-12-20

PEACE8

336 enrolled

Prostatic Neoplasms, Castration-Resistant

NCT06665932 2024-11-12

Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins

100 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04498767 2024-08-26

OligoRARE